Enanta Pharma (ENTA) Misses Q1 EPS by 8c

Enanta Pharma (NASDAQ: ENTA) reported Q1 EPS of ($0.26), $0.08 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $11.9 million versus the consensus estimate of $11.94 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• NVE Corporation names new CEO and expands board to seven members
• RBC Capital Starts Molina Healthcare (MOH) at Sector Perform